vs
Orthofix Medical Inc.（OFIX）与CPI Card Group Inc.（PMTS）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是CPI Card Group Inc.的1.4倍（$219.9M vs $153.1M），CPI Card Group Inc.净利率更高（4.8% vs -1.0%，领先5.8%），CPI Card Group Inc.同比增速更快（22.3% vs 2.0%），CPI Card Group Inc.自由现金流更多（$35.2M vs $16.8M），过去两年CPI Card Group Inc.的营收复合增速更高（16.9% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
CPI Card Group Inc.是知名的支付卡生产及配套解决方案供应商，主营接触式、非接触式信用卡、借记卡、预付卡的制造与个性化定制服务，客户以北美地区的金融机构、金融科技企业及零售品牌为主。
OFIX vs PMTS — 直观对比
营收规模更大
OFIX
是对方的1.4倍
$153.1M
营收增速更快
PMTS
高出20.4%
2.0%
净利率更高
PMTS
高出5.8%
-1.0%
自由现金流更多
PMTS
多$18.4M
$16.8M
两年增速更快
PMTS
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $153.1M |
| 净利润 | $-2.2M | $7.3M |
| 毛利率 | 71.1% | 31.5% |
| 营业利润率 | 0.2% | 12.0% |
| 净利率 | -1.0% | 4.8% |
| 营收同比 | 2.0% | 22.3% |
| 净利润同比 | 92.4% | 8.5% |
| 每股收益（稀释后） | $-0.05 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXPMTS
| Q4 25 | $219.9M | $153.1M | ||
| Q3 25 | $205.6M | $138.0M | ||
| Q2 25 | $203.1M | $129.8M | ||
| Q1 25 | $193.6M | $122.8M | ||
| Q4 24 | $215.7M | $125.1M | ||
| Q3 24 | $196.6M | $124.8M | ||
| Q2 24 | $198.6M | $118.8M | ||
| Q1 24 | $188.6M | $111.9M |
净利润OFIXPMTS
| Q4 25 | $-2.2M | $7.3M | ||
| Q3 25 | $-22.8M | $2.3M | ||
| Q2 25 | $-14.1M | $518.0K | ||
| Q1 25 | $-53.1M | $4.8M | ||
| Q4 24 | $-29.1M | $6.8M | ||
| Q3 24 | $-27.4M | $1.3M | ||
| Q2 24 | $-33.4M | $6.0M | ||
| Q1 24 | $-36.0M | $5.5M |
毛利率OFIXPMTS
| Q4 25 | 71.1% | 31.5% | ||
| Q3 25 | 72.2% | 29.7% | ||
| Q2 25 | 68.7% | 30.9% | ||
| Q1 25 | 62.8% | 33.2% | ||
| Q4 24 | 69.0% | 34.1% | ||
| Q3 24 | 68.7% | 35.8% | ||
| Q2 24 | 67.8% | 35.7% | ||
| Q1 24 | 67.5% | 37.1% |
营业利润率OFIXPMTS
| Q4 25 | 0.2% | 12.0% | ||
| Q3 25 | -8.3% | 9.4% | ||
| Q2 25 | -7.9% | 7.3% | ||
| Q1 25 | -25.2% | 11.5% | ||
| Q4 24 | -5.3% | 12.7% | ||
| Q3 24 | -9.6% | 14.3% | ||
| Q2 24 | -12.5% | 12.5% | ||
| Q1 24 | -15.6% | 12.6% |
净利率OFIXPMTS
| Q4 25 | -1.0% | 4.8% | ||
| Q3 25 | -11.1% | 1.7% | ||
| Q2 25 | -6.9% | 0.4% | ||
| Q1 25 | -27.4% | 3.9% | ||
| Q4 24 | -13.5% | 5.4% | ||
| Q3 24 | -13.9% | 1.0% | ||
| Q2 24 | -16.8% | 5.1% | ||
| Q1 24 | -19.1% | 4.9% |
每股收益（稀释后）OFIXPMTS
| Q4 25 | $-0.05 | $0.62 | ||
| Q3 25 | $-0.57 | $0.19 | ||
| Q2 25 | $-0.36 | $0.04 | ||
| Q1 25 | $-1.35 | $0.40 | ||
| Q4 24 | $-0.76 | $0.56 | ||
| Q3 24 | $-0.71 | $0.11 | ||
| Q2 24 | $-0.88 | $0.51 | ||
| Q1 24 | $-0.95 | $0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $21.7M |
| 总债务越低越好 | — | $286.7M |
| 股东权益账面价值 | $450.0M | $-17.3M |
| 总资产 | $850.6M | $403.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFIXPMTS
| Q4 25 | $82.0M | $21.7M | ||
| Q3 25 | $62.9M | $16.0M | ||
| Q2 25 | $65.6M | $17.1M | ||
| Q1 25 | $58.0M | $31.5M | ||
| Q4 24 | $83.2M | $33.5M | ||
| Q3 24 | $30.1M | $14.7M | ||
| Q2 24 | $26.4M | $7.5M | ||
| Q1 24 | $27.0M | $17.1M |
总债务OFIXPMTS
| Q4 25 | — | $286.7M | ||
| Q3 25 | $157.2M | $308.4M | ||
| Q2 25 | $157.0M | $310.9M | ||
| Q1 25 | $156.9M | $280.7M | ||
| Q4 24 | $157.0M | $280.4M | ||
| Q3 24 | $118.5M | $280.2M | ||
| Q2 24 | $118.0M | $269.7M | ||
| Q1 24 | $118.2M | $265.3M |
股东权益OFIXPMTS
| Q4 25 | $450.0M | $-17.3M | ||
| Q3 25 | $442.5M | $-25.7M | ||
| Q2 25 | $458.3M | $-29.0M | ||
| Q1 25 | $458.3M | $-29.7M | ||
| Q4 24 | $503.1M | $-35.6M | ||
| Q3 24 | $525.9M | $-42.8M | ||
| Q2 24 | $546.0M | $-44.6M | ||
| Q1 24 | $570.3M | $-48.5M |
总资产OFIXPMTS
| Q4 25 | $850.6M | $403.2M | ||
| Q3 25 | $832.6M | $407.1M | ||
| Q2 25 | $837.2M | $399.8M | ||
| Q1 25 | $823.1M | $351.9M | ||
| Q4 24 | $893.3M | $349.7M | ||
| Q3 24 | $867.9M | $342.3M | ||
| Q2 24 | $882.0M | $321.4M | ||
| Q1 24 | $906.0M | $319.8M |
负债/权益比OFIXPMTS
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $39.6M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $35.2M |
| 自由现金流率自由现金流/营收 | 7.6% | 23.0% |
| 资本支出强度资本支出/营收 | 4.9% | 2.9% |
| 现金转化率经营现金流/净利润 | — | 5.39× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $41.3M |
8季度趋势，按日历期对齐
经营现金流OFIXPMTS
| Q4 25 | $27.7M | $39.6M | ||
| Q3 25 | $12.4M | $10.0M | ||
| Q2 25 | $11.6M | $4.3M | ||
| Q1 25 | $-18.4M | $5.6M | ||
| Q4 24 | $23.7M | $26.7M | ||
| Q3 24 | $11.7M | $12.5M | ||
| Q2 24 | $9.0M | $-4.8M | ||
| Q1 24 | $-18.6M | $8.9M |
自由现金流OFIXPMTS
| Q4 25 | $16.8M | $35.2M | ||
| Q3 25 | $2.5M | $5.3M | ||
| Q2 25 | $4.5M | $533.0K | ||
| Q1 25 | $-25.1M | $292.0K | ||
| Q4 24 | $15.2M | $21.6M | ||
| Q3 24 | $6.3M | $11.1M | ||
| Q2 24 | $-360.0K | $-6.0M | ||
| Q1 24 | $-29.1M | $7.4M |
自由现金流率OFIXPMTS
| Q4 25 | 7.6% | 23.0% | ||
| Q3 25 | 1.2% | 3.8% | ||
| Q2 25 | 2.2% | 0.4% | ||
| Q1 25 | -13.0% | 0.2% | ||
| Q4 24 | 7.0% | 17.3% | ||
| Q3 24 | 3.2% | 8.9% | ||
| Q2 24 | -0.2% | -5.0% | ||
| Q1 24 | -15.4% | 6.6% |
资本支出强度OFIXPMTS
| Q4 25 | 4.9% | 2.9% | ||
| Q3 25 | 4.8% | 3.4% | ||
| Q2 25 | 3.5% | 2.9% | ||
| Q1 25 | 3.5% | 4.3% | ||
| Q4 24 | 4.0% | 4.0% | ||
| Q3 24 | 2.7% | 1.2% | ||
| Q2 24 | 4.7% | 1.0% | ||
| Q1 24 | 5.6% | 1.3% |
现金转化率OFIXPMTS
| Q4 25 | — | 5.39× | ||
| Q3 25 | — | 4.32× | ||
| Q2 25 | — | 8.39× | ||
| Q1 25 | — | 1.17× | ||
| Q4 24 | — | 3.94× | ||
| Q3 24 | — | 9.70× | ||
| Q2 24 | — | -0.79× | ||
| Q1 24 | — | 1.63× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
PMTS
| US Debit And Credit | $128.9M | 84% |
| US Prepaid Debit | $24.4M | 16% |
